The reason for the low THC content in hemp is that most THC is formed in resin glands on the buds and flowers of the female cannabis plant. Industrial hemp is not cultivated to produce buds, and therefore lacks the primary component that forms the marijuana high. Furthermore, industrial hemp has higher concentrations of a chemical called Cannabidiol (CBD) that has a negative effect on THC and lessens its psychoactive effects when smoked in conjunction. 
^ "Regulation 182/2011 Laying Down the Rules and General Principles Concerning Mechanisms for Control by Member States of the Commission’s Exercise of Implementing Powers (Comitology Regulation)", EU Treaties and Legislation, Cambridge University Press, pp. 272–280, 2 August 2018, ISBN 9781108624374, retrieved 25 April 2019 C1 control character in |title= at position 134 (help)

If we have a research link to a website where we sell products or have product information, the exit disclaimer indicates that when you click ok you will leave the hemphealthinc.com website and visit an external link. Links to any informational websites are provided solely as a service to our users. External links provide additional information that may be useful or interesting and has no affiliation to the promotion, sale and distribution of Hemp Health Inc. products. the link does not constitute an endorsement of these organizations by Hemp Health Inc. and none should be inferred.
Although CBD oils aren’t regulated by the FDA, purchasing products stateside from one of the nine states where recreational and medical cannabis use is legal will likely result in a higher-quality product than buying one made with hemp-derived CBD oil imported from abroad, says Martin Lee, director of Project CBD, a nonprofit that promotes medical research into CBD.

Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160
×